- Home
- AG vs ACLX Comparison
AG vs ACLX Comparison
Compare AG & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AG
- ACLX
- Stock Information
- Founded
- AG 1979
- ACLX 2015
- Country
- AG Canada
- ACLX United States
- Employees
- AG N/A
- ACLX N/A
- Industry
- AG Precious Metals
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AG Basic Materials
- ACLX Health Care
- Exchange
- AG Nasdaq
- ACLX Nasdaq
- Market Cap
- AG 4.0B
- ACLX 3.8B
- IPO Year
- AG N/A
- ACLX 2022
- Fundamental
- Price
- AG $7.84
- ACLX $71.14
- Analyst Decision
- AG Buy
- ACLX Strong Buy
- Analyst Count
- AG 2
- ACLX 14
- Target Price
- AG $9.63
- ACLX $114.75
- AVG Volume (30 Days)
- AG 18.4M
- ACLX 408.0K
- Earning Date
- AG 08-14-2025
- ACLX 08-11-2025
- Dividend Yield
- AG 0.25%
- ACLX N/A
- EPS Growth
- AG N/A
- ACLX N/A
- EPS
- AG N/A
- ACLX N/A
- Revenue
- AG $698,532,000.00
- ACLX $76,809,000.00
- Revenue This Year
- AG $89.62
- ACLX N/A
- Revenue Next Year
- AG N/A
- ACLX $108.81
- P/E Ratio
- AG N/A
- ACLX N/A
- Revenue Growth
- AG 33.60
- ACLX N/A
- 52 Week Low
- AG $4.43
- ACLX $47.86
- 52 Week High
- AG $9.48
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- AG 40.83
- ACLX 58.77
- Support Level
- AG $8.14
- ACLX $69.30
- Resistance Level
- AG $8.42
- ACLX $74.43
- Average True Range (ATR)
- AG 0.34
- ACLX 2.53
- MACD
- AG -0.14
- ACLX 0.02
- Stochastic Oscillator
- AG 6.51
- ACLX 58.41
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.